258 related articles for article (PubMed ID: 33499821)
1. Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation.
Wang T; Wu Y; Zhou H; Wu C; Zhang X; Chen Y; Zhao D
BMC Gastroenterol; 2021 Jan; 21(1):38. PubMed ID: 33499821
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
Chen J; Xia YJ; Liu TY; Lai YH; Yu JS; Zhang TH; Ooi S; He YL
BMC Cancer; 2021 May; 21(1):532. PubMed ID: 33971833
[TBL] [Abstract][Full Text] [Related]
3. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a nomogram for Siewert II esophagogastric junction adenocarcinoma: a retrospective analysis.
Jin T; Li ZD; Chen ZH; He FJ; Chen ZW; Liang PP; Hu JK; Yang K
Ther Adv Med Oncol; 2024; 16():17588359241229425. PubMed ID: 38322753
[TBL] [Abstract][Full Text] [Related]
5. Different lymph node staging systems for patients with adenocarcinoma of esophagogastric junction.
Zhou Z; Xie X; Hao N; Diao D; Song Y; Xia P; Dang C; Zhang H
Curr Med Res Opin; 2018 Jun; 34(6):963-970. PubMed ID: 29338535
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes.
Yang Y; Zheng J; Li Y
Eur J Surg Oncol; 2022 May; 48(5):1017-1024. PubMed ID: 34876328
[TBL] [Abstract][Full Text] [Related]
7. Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction.
Zhou Z; Zhang H; Xu Z; Li W; Dang C; Song Y
World J Surg Oncol; 2015 Jun; 13():197. PubMed ID: 26055624
[TBL] [Abstract][Full Text] [Related]
8. Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.
Zhang H; Shang X; Chen C; Gao Y; Xiao X; Tang P; Duan X; Yang M; Jiang H; Yu Z
Oncotarget; 2016 Nov; 7(45):74337-74349. PubMed ID: 27517157
[TBL] [Abstract][Full Text] [Related]
9. Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.
Chen K; Deng X; Yang Z; Yu D; Zhang X; Zhang J; Xie D; He Z; Cheng D
Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):757-764. PubMed ID: 32552040
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram for Siewert type II adenocarcinoma of the esophagogastric junction patients with and without neoadjuvant radiotherapy: a retrospective cohort study.
Guo Z; Wang N; Liu F; Zhao Q
Am J Transl Res; 2022; 14(1):135-149. PubMed ID: 35173834
[TBL] [Abstract][Full Text] [Related]
11. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
12. A New Metastatic Lymph Node Classification-based Survival Predicting Model in Patients With Small Bowel Adenocarcinoma: A Derivation and Validation Study.
Wu S; Chen JN; Zhang QW; Tang CT; Zhang XT; Tang MY; Li XB; Ge ZZ
EBioMedicine; 2018 Jun; 32():134-141. PubMed ID: 29908920
[TBL] [Abstract][Full Text] [Related]
13. Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation.
Liu F; Zhou R; Jiang F; Liu G; Li K; Zhu G
Ann Surg Oncol; 2019 May; 26(5):1292-1300. PubMed ID: 30805805
[TBL] [Abstract][Full Text] [Related]
14. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.
Chen L; Tang K; Wang S; Chen D; Ding K
Cancer Control; 2021; 28():10732748211026668. PubMed ID: 34155922
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
Karstens KF; Ghadban T; Sawez S; Konczalla L; Woestemeier A; Bachmann K; Uzunoglu FG; Tachezy M; Vettorazzi E; Izbicki JR; Reeh M
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):638-643. PubMed ID: 31879051
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
18. Development and external validation of a novel nomogram for predicting cancer-specific survival in patients with ascending colon adenocarcinoma after surgery: a population-based study.
Zhang YF; Ma C; Qian XP
World J Surg Oncol; 2022 Apr; 20(1):126. PubMed ID: 35439983
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
[TBL] [Abstract][Full Text] [Related]
20. A novel risk score system for prognostic evaluation in adenocarcinoma of the oesophagogastric junction: a large population study from the SEER database and our center.
Wang J; Shi L; Chen J; Wang B; Qi J; Chen G; Kang M; Zhang H; Jin X; Huang Y; Zhao Z; Chen J; Song B; Chen J
BMC Cancer; 2021 Jul; 21(1):806. PubMed ID: 34256714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
